Tetraphase Pharmaceuticals (TTPH) - NASDAQ
Company Description
Tetraphase Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of tetracycline antibiotics. Its portfolio includes Eravacycline, TP-271, and TP-6076. These products targets the treatment of urinary tract infections and... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States